4.8 Article

Identification of the novel FOXP3-dependent T-reg cell transcription factor MEOX1 by high-dimensional analysis of human CD4(+) T cells

Journal

FRONTIERS IN IMMUNOLOGY
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1107397

Keywords

Treg cells; MEOX1; Foxp3; regulatory T cells; human CD4

Categories

Ask authors/readers for more resources

Through the analysis of a large transcriptomic dataset of various human CD4(+) T cell conditions, researchers identified six common denominators of CD4(+) T cell functionality. They also discovered that MEOX1, a transcription factor, has a similar expression pattern to FOXP3 in T-reg cells and can be upregulated by IL-2. Knockdown of MEOX1 in T-reg cells significantly affected downstream gene expression programs and T-reg cell suppressive capacity.
CD4(+) T cells play a central role in the adaptive immune response through their capacity to activate, support and control other immune cells. Although these cells have become the focus of intense research, a comprehensive understanding of the underlying regulatory networks that orchestrate CD4(+) T cell function and activation is still incomplete. Here, we analyzed a large transcriptomic dataset consisting of 48 different human CD4(+) T cell conditions. By performing reverse network engineering, we identified six common denominators of CD4(+) T cell functionality (CREB1, E2F3, AHR, STAT1, NFAT5 and NFATC3). Moreover, we also analyzed condition-specific genes which led us to the identification of the transcription factor MEOX1 in T-reg cells. Expression of MEOX1 was comparable to FOXP3 in T-reg cells and can be upregulated by IL-2. Epigenetic analyses revealed a permissive epigenetic landscape for MEOX1 solely in T-reg cells. Knockdown of MEOX1 in T-reg cells revealed a profound impact on downstream gene expression programs and T-reg cell suppressive capacity. These findings in the context of CD4(+) T cells contribute to a better understanding of the transcriptional networks and biological mechanisms controlling CD4(+) T cell functionality, which opens new avenues for future therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available